Security Snapshot

Neurogene Inc. - Common (NGNE) Institutional Ownership

CUSIP: 64135M105

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

111

Shares (Excl. Options)

17.31MFull value: 17,312,066 · shares · 30 Jun 2026

Price

$31.45

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common
Symbol
NGNE on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
17,312,066
Latest holder snapshot 5 signals
Total 13F value
$544,434,662
Portfolio coverage rank
0%
Share change
+344,378
Value change
+$11,086,828
Number of holders
111
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
19,922,830
SEC-reported price per share
$21.56
Insider filing price
$21.56
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NGNE - Neurogene Inc. - Common is tracked under CUSIP 64135M105.
  • 111 institutions reported positions in Q2 2026.
  • 13 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 95 to 111 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $341.97MFull value: $341,973,223 · USD · 31 Mar 2026
    to
    $544.43MFull value: $544,434,662 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 111 institutions filings for Q2 2026.

Open SEC evidence

Security key

64135M105

13F reference period

Q2 2026

13F holders

111

13D/G owners

13

CIK / CUSIP context first

Open Q2 2026 holders NGNE full holder history Neurogene Inc. SEC filings Neurogene Inc. company facts Neurogene Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
13
Security
NGNE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRUDENTIAL FINANCIAL INC 11% $62,076,352 2,231,357 PRUDENTIAL FINANCIAL INC 30 Sep 2026
JENNISON ASSOCIATES LLC 11% $62,013,061 2,229,082 Jennison Associates LLC 30 Sep 2026
Redmile Group, LLC 9.9% 0% $60,121,004 +$574,480 1,572,202 +0.96% Redmile Group, LLC 30 Jun 2026
RTW INVESTMENTS, LP 10% $23,096,955 1,498,829 RTW Investments, LP 31 Dec 2024
EcoR1 Capital, LLC 9.9% $25,005,492 1,442,902 EcoR1 Capital, LLC 30 Sep 2025
Casdin Capital, LLC 8.7% $19,961,513 1,295,361 Casdin Capital, LLC 31 Dec 2024
BlackRock, Inc. 6.8% $15,586,229 1,011,436 BlackRock, Inc. 31 Mar 2025
BAKER BROS. ADVISORS LP 7% -30% $21,254,360 -$10,597,328 991,804 -33% Julian C. Baker 30 Jun 2025
BALYASNY ASSET MANAGEMENT L.P. 5.2% $31,307,317 818,706 BALYASNY ASSET MANAGEMENT L.P. 30 Jun 2026
Trails Edge Capital Partners, LP 4.5% -12% $27,337,202 -$2,681,198 714,885 -8.9% Trails Edge Capital Partners, LP 30 Jun 2026
FMR LLC 3.1% $7,132,965 462,879 FMR LLC 31 Mar 2025
GREAT POINT PARTNERS LLC 3% $6,822,947 442,761 Great Point Partners, LLC 31 Dec 2024
Commodore Capital LP 3% $9,169,168 427,866 Commodore Capital LP 30 Jun 2025
As of 30 Jun 2026, 111 institutional investors reported holding
17.31MFull value: 17,312,066 · shares · 30 Jun 2026
shares of Neurogene Inc. - Common (NGNE). This represents 87% of the company’s total
19.92MFull value: 19,922,830 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
79%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SAMSARA BIOCAPITAL, LLC 8.6% 1,717,127 0% 4.4% $54,003,644
Casdin Capital, LLC 7.8% 1,545,361 +8.8% 2.4% $48,601,603
Redmile Group, LLC 7.1% 1,412,199 -3.2% 3% $44,413,659
RTW INVESTMENTS, LP 6.8% 1,362,456 0% 0.37% $42,849,241
EcoR1 Capital, LLC 6.4% 1,271,342 0% 2% $39,983,706
BlackRock, Inc. 5.3% 1,057,983 +5.3% 0% $33,273,565
BAKER BROS. ADVISORS LP 5% 991,691 0% 0.16% $31,188,682
Balyasny Asset Management L.P. 4.1% 818,706 +14% 0.05% $25,748,307
Trails Edge Capital Partners, LP 3.6% 714,885 -8.7% 3.6% $22,483,133
TORONTO DOMINION BANK 3.4% 681,337 0% 0.04% $21,428,049
VANGUARD CAPITAL MANAGEMENT LLC 2.7% 536,525 +4.2% 0% $16,873,711
JENNISON ASSOCIATES LLC 2.6% 518,582 -1.7% 0.01% $16,309,405
CITADEL ADVISORS LLC 2.1% 408,982 +5.7% 0.01% $12,862,484
GREAT POINT PARTNERS LLC 1.8% 352,180 -30% 2.6% $11,076,061
ArrowMark Colorado Holdings LLC 1.7% 342,453 -35% 0.45% $10,770,147
FMR LLC 1.5% 295,561 -23% 0% $9,295,393
GEODE CAPITAL MANAGEMENT, LLC 1.5% 293,182 +5.1% 0% $9,222,612
STATE STREET CORP 1.1% 224,322 -28% 0% $7,054,927
FRANKLIN RESOURCES INC 1% 204,280 0% $6,424,606
MORGAN STANLEY 0.96% 191,724 -33% 0% $6,029,719
UBS Group AG 0.86% 171,289 -7.7% 0% $5,387,039
BLAIR WILLIAM & CO/IL 0.74% 146,905 -13% 0.01% $4,620,162
Driehaus Capital Management LLC 0.72% 143,528 +338% 0.03% $4,513,956
Point72 Asset Management, L.P. 0.71% 141,920 0.01% $4,463,384
MOORE CAPITAL MANAGEMENT, LP 0.71% 141,636 0.1% $4,454,452

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
12
Headline period
Q2 2026
Rows shown
1-12 of 12
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 48,394 $1,348,405 +$463,878 $27.82 19
2026 Q2 17,312,066 $544,434,662 +$11,086,828 $31.45 111
2026 Q1 16,969,501 $341,973,223 +$9,133,403 $20.16 95
2025 Q4 16,492,025 $339,874,510 +$9,470,657 $20.60 92
2025 Q3 15,299,947 $265,173,378 -$165,308 $17.33 88
2025 Q2 15,388,370 $230,113,281 -$13,642,147 $14.95 81
2025 Q1 16,456,922 $192,796,009 +$733,702 $11.71 83
2024 Q4 16,089,357 $367,798,856 +$14,465,324 $22.86 86
2024 Q3 13,847,659 $581,113,931 +$18,023,436 $41.96 85
2024 Q2 13,265,527 $482,740,723 +$37,443,874 $36.39 66
2024 Q1 12,128,797 $617,303,585 +$152,848,957 $50.90 58
2023 Q4 9,233,865 $178,953,482 +$178,848,733 $19.38 35
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .